Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Lagociclovir

🥰Excellent
Catalog No. T15704Cas No. 92562-88-4
Alias MIV-210

Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.

Lagociclovir

Lagociclovir

🥰Excellent
Purity: 99%
Catalog No. T15704Alias MIV-210Cas No. 92562-88-4
Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.
Pack SizePriceAvailabilityQuantity
1 mg$310In Stock
5 mg$757In Stock
10 mg$1,060In Stock
25 mg$1,580In Stock
50 mg$2,130In Stock
1 mL x 10 mM (in DMSO)$719In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Lagociclovir"

Select Batch
Purity:99%
ee:100%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.
Targets&IC50
HBV (3TC-R):8 μM, HBV (WT):9 μM, HBV (3TC+PMEA-R):15 μM, PMEA-R (HBV):13 μM
In vitro
Lagociclovir (FLG) (6 days) demonstrated inhibitory activity against 3TC-R HBV, wt HBV, PMEA-R HBV, and 3TC+PMEA-R HBV in transiently transfected Huh7 cells, with IC50s of 8 ± 3.8, 9 ± 2.5, 13 ± 3.4, and 15 ± 6.8 μM, respectively [1]. Lagociclovir (0-100 μM; 6 days) also inhibits the replication of HBV wild-type and drug-resistant mutants in transiently transfected Huh7 cells [2].
In vivo
Anti-HBV compound Oral administration of MIV-210 (20 or 60 mg/kg; body weight/day) induced a rapid virological response in chronically infected woodchucks, reducing serum WHV DNA levels by 4.75 log10 and 5.72 log10, respectively, in 2 weeks. MIV-210 at 20 or 60 mg/kg/day reduced the liver WHV DNA load 200- to 2,500-fold from pretreatment levels and, importantly, led to a 2.0 log10 drop in the hepatic content of WHV covalently closed circular DNA. Further, a daily dose of 10 mg/kg decreased the serum WHV load 400-fold after 4 weeks of treatment, and a dose of 5 mg/kg/day was sufficient to maintain this antiviral effect during the following 6-week period.[1]
AliasMIV-210
Chemical Properties
Molecular Weight269.23
FormulaC10H12FN5O3
Cas No.92562-88-4
SmilesO=C1C2=C(N(C=N2)[C@@H]3O[C@H](CO)[C@@H](F)C3)NC(N)=N1
Relative Density.2.01g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 25 mg/mL (92.86 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.7143 mL18.5715 mL37.1430 mL185.7148 mL
5 mM0.7429 mL3.7143 mL7.4286 mL37.1430 mL
10 mM0.3714 mL1.8571 mL3.7143 mL18.5715 mL
20 mM0.1857 mL0.9286 mL1.8571 mL9.2857 mL
50 mM0.0743 mL0.3714 mL0.7429 mL3.7143 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Lagociclovir | purchase Lagociclovir | Lagociclovir cost | order Lagociclovir | Lagociclovir chemical structure | Lagociclovir in vivo | Lagociclovir in vitro | Lagociclovir formula | Lagociclovir molecular weight